AbbVie (ABBV) stands out after its Allergan acquisition thanks to a transformed portfolio and higher long-term growth ...

The prevalence of T2D among a cohort of patients in Italy with SSc was lower than national estimates and associated with distinct vascular and cardiopulmonary features.